Optimum processing conditions for a trivalent-inactivated bovine viral diarrhea virus (BVDV) vaccine using field strains and immunogenicity of candidate formulations with different adjuvants
- PMID: 39589623
- DOI: 10.1007/s11259-024-10608-5
Optimum processing conditions for a trivalent-inactivated bovine viral diarrhea virus (BVDV) vaccine using field strains and immunogenicity of candidate formulations with different adjuvants
Abstract
Bovine viral diarrhea virus (BVDV) is among the common bovine pathogens worldwide. One of the prominent protection measures of BVDV is vaccination. This study aimed to determine the growth characteristics, inactivation kinetics of vaccine candidates using local BVDV strains [TR-26 (BVDV-1f), TR-21 (BVDV-1l), and TR-15 (BVDV-2b)], and the serological response in experimental animals to inactivated BVDV vaccine formulations prepared with different adjuvants. Optimum MOI values for BVDV strains TR-26, TR-21, and TR-15 were determined as 0.1, 1.0, and 0.01, respectively. In addition, growth curves of TR-26, TR-21, and TR-15 strains were created, and it was determined that they reached the highest titers at 12, 48, and 36 h p.i., respectively. The strains TR-26, TR-21, and TR-15 with titers of 106.5, 106.5, and 105.25 TCID50/ml were completely inactivated by 1 mM binary ethyleneimine (BEI) at the 10th, 16th, and 10th hours of treatment, respectively. Guinea pigs were immunized with four vaccine formulations (F1, F2, F3, F4), two with aluminum-based [Al(OH)3, Al(OH)3+Saponin] and two with oil-based (ISA 50 and ISA 206) adjuvants. Neutralization tests were applied to determine the humoral immune response developed after vaccination. Both homologous and heterologous BVDV strains were used for evaluations. Oil adjuvanted vaccines were more efficient to induce antibody titers compared to Al(OH)3-based vaccines. In addition, between the oil adjuvanted vaccines, the titers of neutralizing antibodies obtained by Montanide® ISA 206 formulation were significantly higher than in Montanide® ISA 50 (p < 0.05). Post-vaccinal neutralizing antibodies were detected in the first sampling at 21st day and lasted longer than a 111 days period. The highest antibody response in Guinea pigs was for the strain TR-15. The availability of using BVDV-lf, 1l, and 2b local strains in vaccines and their effectiveness against homologous and heterologous strains have been demonstrated.
Keywords: BVDV; Growth curve; Guinea pig; Immunization; Inactivated vaccine; Inactivation kinetics.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Ethical approval: The experiment conducted according to ethical rules determined by the regulations and permitted by Bursa Uludag University Ethical Commity for Experimental Animals (BUÜ-HADYEK 2018-08/03). Competing interests: The authors declare no competing interests.
Similar articles
-
A novel killed oil adjuvanted bovine viral diarrhea virus vaccine protects from viremia and clinical manifestations: an immune response and challenge study in cattle.Vet Res Commun. 2025 Jun 13;49(4):224. doi: 10.1007/s11259-025-10792-y. Vet Res Commun. 2025. PMID: 40512232 Free PMC article.
-
Serological response of guinea pigs to oily and aqueous inactivated vaccines containing a Brazilian isolate of the Bovine Viral Diarrhea Virus (BVDV).Res Vet Sci. 2011 Oct;91(2):311-5. doi: 10.1016/j.rvsc.2010.12.010. Epub 2011 Feb 12. Res Vet Sci. 2011. PMID: 21316721
-
Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.Vet Immunol Immunopathol. 2014 Aug 15;160(3-4):288-92. doi: 10.1016/j.vetimm.2014.04.007. Epub 2014 Apr 29. Vet Immunol Immunopathol. 2014. PMID: 24880701
-
BVDV vaccination in North America: risks versus benefits.Anim Health Res Rev. 2015 Jun;16(1):27-32. doi: 10.1017/S1466252315000080. Anim Health Res Rev. 2015. PMID: 26050569 Review.
-
Host Immune Response to Bovine Viral Diarrhea Virus (BVDV): Insights and Strategies for Effective Vaccine Design.Vaccines (Basel). 2025 Apr 25;13(5):456. doi: 10.3390/vaccines13050456. Vaccines (Basel). 2025. PMID: 40432068 Free PMC article. Review.
Cited by
-
A novel killed oil adjuvanted bovine viral diarrhea virus vaccine protects from viremia and clinical manifestations: an immune response and challenge study in cattle.Vet Res Commun. 2025 Jun 13;49(4):224. doi: 10.1007/s11259-025-10792-y. Vet Res Commun. 2025. PMID: 40512232 Free PMC article.
-
Codonopsis pilosula Polysaccharides Exert Antiviral Effect Through Activating Immune Function in a Macrophage Model of Bovine Viral Diarrhea Virus Infection.Vet Sci. 2025 Apr 27;12(5):415. doi: 10.3390/vetsci12050415. Vet Sci. 2025. PMID: 40431508 Free PMC article.
References
-
- Abd El-Fadil M, El Hawary R, Warda F (2017) Keeping quality of inactivated respiratory virus vaccines (Pneumo-5). Benha Vet Med J 33:193–199. https://doi.org/10.21608/bvmj.2017.30270 - DOI
-
- Abedon ST, Bartom E (2013) Multiplicity of infection. In: Maloy S, Hughes K (eds.) Brenner’s Encyclopedia of Genetics: Second Edition. Elsevier Inc., pp 509–510 - DOI
-
- Alpay G, Yeşilbağ K (2015) Serological relationships among subgroups in bovine viral diarrhea virus genotype 1 (BVDV-1). Vet Microbiol 175:1–6. https://doi.org/10.1016/j.vetmic.2014.10.034 - DOI - PubMed
-
- Alpay G, Yeşi̇lbağ K (2019) Neutralizing antibody titers against field strains of bovine viral diarrhea virus after vaccination with three commercial vaccines. Turkish J Vet Anim Sci 43:716–723. https://doi.org/10.3906/vet-1803-43 - DOI
-
- Baumbach LF, Mósena ACS, Alves RS et al (2023) HoBi-like pestivirus is highly prevalent in cattle herds in the Amazon Region (Northern Brazil). Viruses 15:453. https://doi.org/10.3390/v15020453 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous